AGI vs ALB

The Advanced Deterministic Scorecard reveals a mixed financial profile: the Piotroski F-Score of 4/9 indicates borderline financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong profitability metrics and robust earnings growth, elevated valuation multiples and inconsistent quarterly earnings surprises weigh on sustainability. The stock trades significantly above the Graham Number of $16.89 and near the intrinsic value of $38.94, suggesting limited margin of safety. Analysts maintain a strong_buy consensus, but technical trend and insider sentiment are weak, indicating caution despite favorable sector-relative fundamentals.

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant deterioration in fundamental performance. Despite a strong recent price run-up (+115.4% over 1Y), the company is unprofitable (negative profit and operating margins), has negative earnings growth (YoY), and trades at an extremely high forward P/E of 82.85. While the balance sheet shows a healthy current ratio and manageable debt/equity of 0.37, the lack of Altman Z-Score and Graham Number, combined with deteriorating profitability and insider selling, raises serious concerns about sustainability. The analyst target price of $165.06 implies 13% downside from current levels, reinforcing overvaluation relative to fundamentals.